Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

LAG-3

Lymphocyte activation gene 3 (LAG-3), also known as CD223, is a type I transmembrane protein that belongs to the immunoglobulin superfamily (IgSF). It is expressed on the surface of activated CD4+ and CD8+ T cells, regulatory T cells, Tr1 cells, natural killer (NK) cells, and plasmacytoid dendritic cells (pDCs) as dimers or oligomers. LAG-3 serves as a cell surface suppressor receptor that plays a crucial regulatory role in the immune system.

Relatlimab
T9901A-0011673516-98-7
Relatlimab(BMS-986016) is a monoclonal antibody targeting human anti-LAG-3, generated by immunization of transgenic mice with human immunoglobulin carrying recombinant LAG-3 protein.Relatlimab has a blocking effect, blocking the interaction of LAG-3 MHC II (IC50: 0.67 nM) and LAG-3 FGL1 (IC50: 0.019 nM). Relatlimab is often used with Nivoluma to treat advanced melanoma.
  • 157 €
In Stock
Size
QTY
Ieramilimab
T78247
Ieramilimab (LAG525) is a humanized antibody targeting LAG-3 with potential anticancer activity, blocking its interaction with MHC-II molecules by binding to LAG-3.Pranlukast hemihydrate can be used to study malignant tumors.
  • 177 €
In Stock
Size
QTY